S&P Futures
4,144.50 +14.00 (+0.34%) Dow Futures
34,110.00 +115.00 (+0.34%) Nasdaq Futures
12,598.25 +53.00 (+0.42%) Russell 2000 Futures
1,957.80 +7.90 (+0.41%) Crude Oil
78.55 +0.08 (+0.10%) Gold
1,892.70 +2.00 (+0.11%)
Aethlon Medical, Inc. (AEMD)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.5898 |
| Open | 0.5668 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 1000 |
| Day's Range | 0.5668 - 0.6150 |
| 52 Week Range | 0.2300 - 2.4600 |
| Volume | |
| Avg. Volume | 1,111,875 |
| Market Cap | 13.765M |
| Beta (5Y Monthly) | 1.02 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Aethlon Medical, Inc. (NASDAQ:AEMD) Is About To Turn The Corner
With the business potentially at an important milestone, we thought we'd take a closer look at Aethlon Medical, Inc.'s...
- Insider Monkey
10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat. If you want to explore similar healthcare and biotech stocks, you can also take a look at 5 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat. In May of 2022, the first case of the monkeypox […]
- Benzinga
Aethlon Medical To Start Lab Studies For Hemopurifier For Monkeypox
Aethlon Medical Inc (NASDAQ: AEMD) said it is commissioning a new in vitro binding experiment to confirm that the Hemopurifier effectively captures the current strain of the monkeypox virus. The Hemopurifier is an extracorporeal (i.e., outside of the body) blood filtration device designed to selectively remove harmful particles from the circulatory system using lectin affinity agents. In 2008, the company conducted an in vitro study demonstrating that the Hemopurifier effectively bound and remov
